These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 6018195)

  • 1. Leukocyte oxidase: defective activity in chronic granulomatous disease.
    Baehner RL; Nathan DG
    Science; 1967 Feb; 155(3764):835-6. PubMed ID: 6018195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity.
    Cooper MR; DeChatelet LR; McCall CE; LaVia MF; Spurr CL; Baehner RL
    J Clin Invest; 1972 Apr; 51(4):769-78. PubMed ID: 4401271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative nitroblue tetrazolium test in chronic granulomatous disease.
    Baehner RL; Nathan DG
    N Engl J Med; 1968 May; 278(18):971-6. PubMed ID: 4384563
    [No Abstract]   [Full Text] [Related]  

  • 4. Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies.
    Baehner RL; Gilman N; Karnovsky ML
    J Clin Invest; 1970 Apr; 49(4):692-700. PubMed ID: 4392648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bactericidal capacity and phagocytosis-associated metabolism of fetal pig leukocytes.
    Holmes B; Day N; Haseman J; Good RA
    Infect Immun; 1972 Feb; 5(2):232-7. PubMed ID: 4635500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes.
    Baehner RL; Boxer LA; Davis J
    Blood; 1976 Aug; 48(2):309-13. PubMed ID: 949553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory models of chronic granulomatous disease.
    Holmes B; Good RA
    J Reticuloendothel Soc; 1972 Aug; 12(2):216-37. PubMed ID: 4263057
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic activity of polymorphonuclear leukocytes in sickle cell anemia.
    Dimitrov NV; Douwes FR; Bartolotta B; Nochumson S; Toth MA
    Acta Haematol; 1972; 47(5):283-91. PubMed ID: 4625459
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease.
    Baehner RL; Nathan DG; Karnovsky ML
    J Clin Invest; 1970 May; 49(5):865-70. PubMed ID: 5441540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis.
    Goldstein IM; Feit F; Weissmann G
    J Immunol; 1975 Jan; 114(1 Pt 2):516-8. PubMed ID: 1090664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of polyanions on NBT Reductions hexose monophosphate shunt activity, and ultrastructure of polymorphonuclear leukocytes.
    Czarnetzki BM; Cowan DH; Belcher RW
    Am J Clin Pathol; 1975 Jul; 64(1):34-40. PubMed ID: 1155373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexose monophosphate shunt activity and oxygen consumption during phagocytosis: temporal sequence. 1.
    DeChatelet LR; Wang P; McCall CE
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1434-6. PubMed ID: 5057606
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of nitro blue tetrazolium dye on the hexose monophosphate shunt activity of human polymorphonuclear leukocytes.
    DeChatelet LR; Shirley PS
    Biochem Med; 1975 Dec; 14(4):391-8. PubMed ID: 1227515
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte degranulation and vacuole formation in patients with chronic granulomatous disease of childhood.
    Kauder E; Kahle LL; Moreno H; Partin JC
    J Clin Invest; 1968 Aug; 47(8):1753-62. PubMed ID: 5666110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease.
    Baehner RL; Karnovsky ML
    Science; 1968 Dec; 162(3859):1277-9. PubMed ID: 4387010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced phagocytic capacity. The biologic basis for the elevated histochemical nitroblue tetrazolium reaction.
    McCall CE; DeChatelet LR; Butler R; Brown D
    J Clin Invest; 1974 Nov; 54(5):1227-34. PubMed ID: 4153897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis-associated metabolism and enzymes in the rat polymorphonuclear leukocyte.
    Reed PW; Tepperman J
    Am J Physiol; 1969 Feb; 216(2):223-30. PubMed ID: 5766973
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity.
    Mandell GL; Rubin W; Hook EW
    J Clin Invest; 1970 Jul; 49(7):1381-8. PubMed ID: 4393490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of peroxide in the stimulation of the hexose monophosphate shunt during phagocytosis by polymorphonuclear leukocytes.
    Noseworthy J; Karnovsky ML
    Enzyme; 1972; 13(1):110-31. PubMed ID: 5075803
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acid oxidase in leukocytes: evidence against a major role in phagocytosis.
    DeChatelet LR; McCall CE; Cooper MR
    Infect Immun; 1972 Apr; 5(4):632-3. PubMed ID: 4404631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.